In the last trading session, 1.33 million shares of the Lyra Therapeutics Inc (NASDAQ:LYRA) were traded, and its beta was 0.20. Most recently the company’s
Lyra Therapeutics Inc (NASDAQ:LYRA)’s traded shares stood at 2.27 million during the last session, with the company’s beta value hitting 0.11. At the close of
In the last trading session, 2.44 million Lyra Therapeutics Inc (NASDAQ:LYRA) shares changed hands as the company’s beta touched 0.05. With the company’s per share
In the last trading session, 4.23 million Lyra Therapeutics Inc (NASDAQ:LYRA) shares changed hands as the company’s beta touched 0.08. With the company’s per share
In last trading session, Lyra Therapeutics Inc (NASDAQ:LYRA) saw 1.96 million shares changing hands with its beta currently measuring 0.04. Company’s recent per share price
Lyra Therapeutics Inc (NASDAQ:LYRA) has a beta value of 0.04 and has seen 0.86 million shares traded in the recent trading session. The LYRA stock
Lyra Therapeutics Inc (NASDAQ:LYRA)’s traded shares stood at 0.84 million during the last session, with the company’s beta value hitting -0.08. At the close of
Lyra Therapeutics Inc (NASDAQ:LYRA)’s traded shares stood at 1.03 million during the last session, with the company’s beta value hitting -0.06. At the close of
In the last trading session, 1.46 million Lyra Therapeutics Inc (NASDAQ:LYRA) shares changed hands as the company’s beta touched -0.08. With the company’s per share
In recent trading session, Lyra Therapeutics Inc (NASDAQ:LYRA) saw 0.57 million shares changing hands at last check today with its beta currently measuring -0.06. Company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
